Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1177-1185

  Mahale, Parag ^a   Kontoyiannis, Dimitrios P ^a   Chemaly, Roy F ^a   Jiang, Ying ^a   Hwang, Jessica P ^a   Davila, Marta ^a   Torres, Harrys A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Hepatitis C virus; Lymphoma; Reactivation; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; CISPLATIN; CORTICOSTEROID; CYTARABINE; GEMCITABINE; METHOTREXATE; NAVELBINE; PACLITAXEL; RITUXIMAB;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEPATITIS C; HUMAN; LEUKEMIA; LYMPHOCYTOPENIA; LYMPHOMA; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS LOAD; VIRUS REACTIVATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRUS ACTIVATION;

EID: 84869234475     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.031     Document Type: Article

References (38)

1. J.B. Wong, G.M. McQuillan, J.G. McHutchison, and T. Poynard Estimating future hepatitis C morbidity, mortality, and costs in the United States Am J Public Health 90 2000 1562 1569
2. H.A. Torres, and M. Davila Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer Nat Rev Clin Oncol 9 3 2012 156 166
3. E. Zuckerman, T. Zuckerman, D. Douer, D. Qian, and A.M. Levine Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies Cancer 83 1998 1224 1230
4. M. Luppi, G. Longo, M.G. Ferrari, L. Ferrara, R. Marasca, and P. Barozzi Additional neoplasms and HCV infection in low-grade lymphoma of MALT type Br J Haematol 94 1996 373 375
5. T. Kawatani, T. Suou, F. Tajima, K. Ishiga, H. Omura, and A. Endo Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies Eur J Haematol 67 2001 45 50
6. S. Vento, F. Cainelli, F. Mirandola, L. Cosco, G. Di Perri, and M. Solbiati Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus Lancet 347 1996 92 93
7. D. Ennishi, Y. Maeda, N. Niitsu, M. Kojima, K. Izutsu, and J. Takizawa Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis Blood 116 2010 5119 5125
8. D. Ennishi, Y. Terui, M. Yokoyama, Y. Mishima, S. Takahashi, and K. Takeuchi Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy Am J Hematol 83 2008 59 62
9. L. Nosotti, M. D'Andrea, A. Pitidis, F. Pimpinelli, M.L. Dessanti, and F. Pisani Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy Scand J Infect Dis 44 1 2012 70 73
10. T.L. Fong, B. Valinluck, S. Govindarajan, F. Charboneau, R.H. Adkins, and A.G. Redeker Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C Gastroenterology 107 1994 196 199
11. C. de Pree, E. Giostra, A. Galetto, L. Perrin, and G.B. Zulian Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma Ann Oncol 5 1994 861 862
12. M.E. Melisko, R. Fox, and A. Venook Reactivation of hepatitis C virus after chemotherapy for colon cancer Clin Oncol (R Coll Radiol) 16 2004 204 205
13. D. Santini, A. Picardi, B. Vincenzi, P. Binetti, C. Massacesi, and A. La Cesa Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient Cancer Invest 21 2003 162 163
14. I.S. Sheen, Y.F. Liaw, D.Y. Lin, and C.M. Chu Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study J Hepatol 24 1996 525 531
15. M. Ozguroglu, A. Bilici, H. Turna, and S. Serdengecti Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma Med Oncol 21 2004 67 72
16. V.J. Navarro, and J.R. Senior Drug-related hepatotoxicity N Engl J Med 354 2006 731 739
17. B.H. McGovern, C.E. Birch, M.J. Bowen, L.L. Reyor, E.H. Nagami, and R.T. Chung Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria Clin Infect Dis 49 2009 1051 1060
18. G. Rossi, A. Pelizzari, M. Motta, and M. Puoti Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy Br J Haematol 115 2001 58 62
19. H.P. Dienes, H. Popper, W. Arnold, and H. Lobeck Histologic observations in human hepatitis non-A, non-B Hepatology 2 1982 562 571
20. M. Mondelli, G.M. Vergani, A. Alberti, D. Vergani, B. Portmann, and A.L. Eddleston Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes J Immunol 129 1982 2773 2778
21. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study Gastroenterology 127 2004 1372 1380
22. K.M. Field, C. Dow, and M. Michael Part I: liver function in oncology: biochemistry and beyond Lancet Oncol 9 2008 1092 1101
23. Y. Loriot, G. Perlemuter, D. Malka, F. Penault-Llorca, V. Boige, and E. Deutsch Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy Nat Clin Pract Oncol 5 2008 268 278
24. B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, and D. Ma Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study Blood 92 1998 1927 1932
25. Y. Tsutsumi, H. Kanamori, A. Mori, J. Tanaka, M. Asaka, and M. Imamura Reactivation of hepatitis B virus with rituximab Expert Opin Drug Saf 4 2005 599 608
26. C. Sarrecchia, A. Cappelli, and P. Aiello HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb J Infect Chemother 11 2005 189 191
27. N. Coppola, M. Pisaturo, S. Guastafierro, G. Tonziello, A. Sica, and V. Iodice Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy Dig Liver Dis 44 1 2012 49 54
28. L.E. van der Kolk, J.W. Baars, M.H. Prins, and M.H. van Oers Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 100 2002 2257 2259
29. J.C. Gea-Banacloche Rituximab-associated infections Semin Hematol 47 2010 187 198
30. U. Lazdina, M. Alheim, J. Nystrom, C. Hultgren, G. Borisova, and I. Sominskaya Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent J Gen Virol 84 2003 139 146
31. Z. Stamataki, S. Tilakaratne, D.H. Adams, and J.A. McKeating Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivity PLoS One 6 2011 e25789
32. M.L. Gutierrez, S. Alonso, P. Sanmartin, D. Martin, S. Agudo, and B. Carrascosa Cumulative dose of rituximab is a risk factor of HBV reactivation Hepatology 54 2011 2 suppl; abstr 507
33. L. Arcaini, M. Merli, F. Passamonti, R. Bruno, E. Brusamolino, and P. Sacchi Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas Am J Hematol 85 2010 46 50
34. A.S. Lok, R.H. Liang, E.K. Chiu, K.L. Wong, T.K. Chan, and D. Todd Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 1991 182 188
35. R. Peffault de Latour, V. Levy, T. Asselah, P. Marcellin, C. Scieux, and L. Ades Long-term outcome of hepatitis C infection after bone marrow transplantation Blood 103 2004 1618 1624
36. J.H. Hoofnagle Reactivation of hepatitis B Hepatology 49 2009 S156 165
37. G. Fattovich, L. Brollo, A. Alberti, G. Realdi, P. Pontisso, and G. Giustina Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis Liver 10 1990 141 146
38. Y.F. Liaw, D.I. Tai, C.M. Chu, and T.J. Chen The development of cirrhosis in patients with chronic type B hepatitis: a prospective study Hepatology 8 1988 493 496